|1/31/19 (Cody)||CRBP||$7.22||$9.11 (2/15/19)||+26%||$7.47|
|2/11/19 (Cody)||REPH||$8.37||$10.32 (3/4/19)||+23%||$9.11|
|2/25/19||KPTI (puts)||$5.20||$3.80 (2/25/19)||0||$5.00|
Performance record 2019 represents the potential return on investment (ROI) a trader could have made on our respective picks so far this year. In total, this comes to a 368% potential ROI. We did not personally invest in all of these stocks. The ones that MS Money Moves executives invested in (shares and or options) are CNAT, SCYX, ADMA, KPTI, GALT, and INSY. In every article, the author discloses if they have a position. The fact that we did not invest in a company does not reflect MSMM’s opinion or outlook on the company. We look forward to delivering more money making information helping our team members achieve their financial goals.
To get access to our exclusive money moves take a look at MS Premium.
Let’s get it!
MS Money Move and its Chief Operating Officer who is a scientist and individual investor, as well as its affiliates, are not registered, financial advisors. Our posts should serve as educational material to help you conduct due diligence research. Posts and articles are not directives or recommendations to invest in any security. We reserve the right to buy or sell any security for ourselves without any notification except when required by law. We are not responsible for the action of our affiliates. Investment theses may change due to the variable nature of the securities market. Because of this there is great risk when investing in stocks and options which can result is capital loss. Additionally, past performance by MS Money Moves or any security is not a predictor of future performance. Everyone should conduct their own research and due diligence before making an investment decision. We recommend you consult a financial advisor regarding any investment action.
The biotech sector is especially volatile. Stock prices may fluctuate substantially based on material or nonmaterial developments. We encourage everyone to familiarize themselves with clinical trial processes, relevant terminology, FDA/SEC rules and regulations, and the general processes of drug & therapy development/approval. Always do independent research in a security prior to investing.